This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Lilly Releases Report On Corporate Responsibility Efforts

INDIANAPOLIS, Dec. 5, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has released its 2012-13 Corporate Responsibility Report. The report offers a comprehensive look at the company's progress on numerous corporate responsibility goals and efforts, including:

"Lilly's greatest contribution to society is continuing to discover and develop innovative medicines that help make life better," said John C. Lechleiter, Ph.D., Lilly chairman, president, and chief executive officer. "Being a trustworthy global citizen also requires us to conduct our business ethically, responsibly, and transparently—and to strategically use our resources, knowledge, and capabilities to help improve global health and bring value to patients, society, and shareholders."

Among the report's highlights:

  • Committed to provide $30 million to fight the rising burden of non-communicable diseases (NCDs) in developing nations from 2012-2016 through the Lilly NCD Partnership
  • Pledged an additional $30 million to fund the Lilly MDR-TB Partnership through 2016, focusing on healthcare provider training and improving the supply of and access to safe, effective, and high-quality medications
  • Helped over 300,000 people gain access to our medicines through the U.S. patient-assistance program, Lilly TruAssist, an increase of 18 percent over 2011
  • Since 2011, nearly 600 employees have devoted nearly 24,000 hours to Connecting Hearts Abroad, a program that allows employees to volunteer on company time in countries where people lack basic resources or access to quality health care
  • Donated more than $12 million to the United Way in 2012, a record high for Lilly
  • Added more than 360 new clinical trial sites with minority patient populations of more than 25 percent
  • Received a perfect score of 100 on the Human Rights Campaign's "Best Places to Work: Corporate Index" in 2012
  • Recognized by DiversityInc  as one of the "Top 50 Companies for Diversity," and as a model of workplace flexibility for employees
  • Selected as a 2020 Women on Boards Winning Company for commitment to diversity on the board of directors
  • Decreased water intake by nearly 37 percent compared to 2007
  • Decreased greenhouse gas emissions by nearly 17 percent between 2007 and 2012.

The Lilly 2012-13 Corporate Responsibility Report also serves as Lilly's annual Communication on Progress to the United Nations Global Compact (UNGC). As a signatory of the UNGC, Lilly shares its progress annually on 10 universally accepted principles related to human rights, labor, the environment, and anti-corruption.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,856.78 -278.94 -1.54%
S&P 500 2,071.26 -29.78 -1.42%
NASDAQ 4,927.37 -55.4390 -1.11%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs